Efficacy of an executive function intervention programme in MS: A placebo-controlled and pseudo-randomized trial

Multiple Sclerosis

Volumn 16, Issue 9, 2010, Pages 1148-1151

  Fink, Frauke ^a,b   Rischkau, Eva ^a   Butt, Martina ^a   Klein, Jan ^c   Eling, Paul ^d   Hildebrandt, Helmut ^a,b  

^a KLINIKUM BREMEN OST   (Germany)

^b UNIVERSITY OF OLDENBURG   (Germany)

^c FRAUNHOFER MEVIS   (Germany)

^d RADBOUD UNIVERSITY   (Netherlands)

Author keywords

brain atrophy; cognitive intervention; executive functioning; multiple sclerosis

Indexed keywords

PLACEBO;

ADULT; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LEARNING; MALE; MULTIPLE SCLEROSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ATROPHY; BRAIN; COGNITION; COGNITION DISORDERS; DOUBLE-BLIND METHOD; EXECUTIVE FUNCTION; FEMALE; GERMANY; HUMANS; LEARNING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PLACEBO EFFECT; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TREATMENT OUTCOME; VERBAL BEHAVIOR;

EID: 77956333880     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510375440     Document Type: Article

References (12)

1. Vogt A., Kappos L., Calabrese P., et al. Working memory training in patients with multiple sclerosis - comparison of two different training schedules. Restor Neurol Neurosci 2009 ; 27: 225-235.
2. O'Brien AR, Chiaravalloti N., Goreover Y. and DeLuca J. Evidence-based cognitive rehabilitation for patients with multiple sclerosis: a review of the literature. Arch Phys Med Rehabil 2008 ; 89: 761-769.
3. Müller SV, Hildebrandt H. and Münte TF Kognitive Therapie bei Störung der Exekutivfunktionen. Göttingen: Hogrefe, 2004.
4. Hildebrandt H., Brokate B., Fink F., Müller SV and Eling P. Impaired stimulus-outcome but preserved stimulus-response shifting in young addicts. J Clin Exp Neuropsychol 2008 ; 29: 1-10.
5. Hasomed. Rehacom. Magdeburg: Hasomed GmbH Eigenverlag, 2006.
6. Lukas C., Hahn HK, Bellenberg B., Rexilius J., Schmid G. and Schimrigk SK Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volume-try in multiple sclerosis. Neuroradiology 2004 ; 46: 906-915.
7. Niemann H., Sturm W., Thöne-Otto AI and Willmes K. Deutsche Normierung des California Verbal Learning Tests. Leipzig, 2002.
8. Dahl G. Reduzierter Wechsler Intelligenztest, 2 nd edn. Königstein Hain, 1986.
9. Cutter GR, Baier ML, Rudick, Cookfair DL, Fischer JS and Petkau J. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999 ; 122: 871-882.
10. Fink F., Klein J., Lanz M., Mitrovics T., Lentschig M., Hahn HK, and Hildebrandt H. Comparison of diffusion tensor based tractography and quantified brain atrophy for analysing demyelination and axonal loss in MS. J Neuroimaging 2009. doi: 10.1111/j.1552-6569.2009.00377.x.
11. Fink F., Eling P., Rischkau E., Beyer N., Tomandl B. and Hildebrandt H. The association between California Verbal Learning Test performance and fibre impairment in multiple sclerosis: evidence from diffusion tensor imaging. Mult Scler 2010 ; 16: 332-341.
12. Remijnse PL, Nielen MMA, van Balkom Ajlm, Cath DC, van Oppen P. and Uylings HBM. Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. Arch Gen Psychiatry 2006 ; 63: 1225-1236.